In Vivo Molecular Imaging Agents Help in Early Disease Detection and Treatment

A new line of imaging agents for in vivo molecular imaging applications allows non-invasive measurement of biologic processes within a living organism. In contrast to conventional diagnostic imaging that highlights conditions caused by disease, molecular imaging identifies molecular abnormalities that are the basis of disease at a very early stage, which can accelerate the development of treatment alternatives that could help cure that disease.

Once attached to a molecule and injected into an organism, X-Sight imaging agents, developed by Eastman Kodak Molecular Imaging Systems group (Rochester, NY, USA), will travel to the target (such as a tumor) and highlight the region of interest. X-Sight imaging agents are non-toxic, making them safe for research studies in areas such as oncology, cardiology, diabetes, and inflammation. They are uniquely designed to provide significant advantages over currently available agents, enabling researchers to perform innovative research studies that could lead to a better understanding of the origin of these diseases.

X-Sight imaging agents deliver excellent brightness and enhanced stability, providing researchers a versatile platform for molecular imaging. These imaging agents are available in several distinct varieties and can be adapted to a wide range of applications.

"The launch of X-Sight Imaging Agents is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research,” commented Shahram Hejazi, Ph.D., worldwide general manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications.”

X-Sight imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March 2007. Kodak plans to introduce additional imaging agents throughout 2007.

Kodak's Molecular Imaging Systems group--part of Kodak's Health Group--develops and markets high performance digital imaging systems, imaging agents, film, and accessories for the life science research and drug discovery industries.


Related Links:
Kodak